<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href='static/style.xsl' type='text/xsl'?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T08:59:58Z</responseDate><request verb="GetRecord" identifier="oai:ecommons.cornell.edu:1813/120965" metadataPrefix="dim">https://ecommons.cornell.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:ecommons.cornell.edu:1813/120965</identifier><datestamp>2026-05-15T17:54:03Z</datestamp><setSpec>com_1813_35</setSpec><setSpec>col_1813_47</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author">Phuong, Daryl</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="chair" lang="en_US">Schimenti, John</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember" lang="en_US">Nikitin, Alexander</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember" lang="en_US">White, Andrew</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2026-04-02T18:53:11Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2026-04-02T18:53:11Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued">2025-08</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">ProQuest Submission ID: 15010</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other">ProQuest Publication ID: 32043448</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://hdl.handle.net/1813/120965</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="doi">https://doi.org/10.7298/vdcb-2a28</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="bibid">17422398</dim:field>
   <dim:field mdschema="dc" element="description" lang="en_US">131 pages</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">By 2050, ovarian cancer deaths are projected to exceed 350,000 annually, a 70% increase from 2022. Of these, 70% will be high-grade serous ovarian carcinoma (HGSC), the most aggressive subtype. Understanding HGSC is crucial for improving patient outcomes, but research has been hindered by a lack of recurrent mutations aside from TP53 and challenges related to the homologous recombination deficiency of HGSC, which can lead to significant genome loss. In my studies, I demonstrate that tubal epithelial (TE) organoids from the mouse uterine tube can be used in combinatorial screening to identify HGSC drivers and cell of origin. Using CRISPR knockout libraries, we found that Map2k4 mutations primarily form papillary tumor phenotypes, while Nf1 mutations lead to mesenchymal phenotypes. Map2k4 mutations were more sensitive to paclitaxel and resistant to trametinib. Additionally, TE organoid models closely reflect their in vivo counterparts, with SLC1A3+ cells more likely to form organoids and exhibit ciliation. These findings highlight the potential of TE organoid models for studying HGSC genetic drivers and the cell of origin. Overall, I demonstrate the potential of this system for use in future human studies, particularly in exploring spontaneous mutations caused by tumor promoting environmental factors. These findings could lead to the development of a more thorough diagnostic and prognostic pipeline and database that help monitor and improve patient survival.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso">en</dim:field>
   <dim:field mdschema="dc" element="rights">Attribution-NonCommercial-NoDerivatives 4.0 International</dim:field>
   <dim:field mdschema="dc" element="rights" qualifier="uri">https://creativecommons.org/licenses/by-nc-nd/4.0/</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Cancer</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">CRISPR</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Drugs</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Genes</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Organoids</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Ovarian</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">UTILIZATION OF MOUSE TUBAL EPITHELIAL ORGANOIDS TO STUDY GENE COMBINATIONS OF HIGH GRADE SEROUS OVARIAN CARCINOMA AND CELL OF ORIGIN</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">dissertation or thesis</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="discipline">Biochemistry, Molecular and Cell Biology</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="grantor">Cornell University</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="level">Doctor of Philosophy</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="name">Ph. D., Biochemistry, Molecular and Cell Biology</dim:field>
   <dim:field mdschema="dcterms" element="license">https://hdl.handle.net/1813/59810.2</dim:field>
   <dim:field mdschema="dspace" element="entity" qualifier="type">Publication</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="collection" authority="https://ecommons.cornell.edu/handle/1813/47" confidence="600">Cornell Theses and Dissertations</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="author">Phuong, Daryl</dim:field>
   <dim:field mdschema="cris" element="virtualsource" qualifier="collection">5893a6ea-7af3-41d7-abc6-04bcd26ab5df</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="cerif" element="openaire" authority="" confidence="-1">&lt;Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="6ed556ff-048f-4dd1-ba9a-de12516cb1fe">
	&lt;Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843&lt;/Type>
	&lt;Language>en&lt;/Language>
   	&lt;Title>UTILIZATION OF MOUSE TUBAL EPITHELIAL ORGANOIDS TO STUDY GENE COMBINATIONS OF HIGH GRADE SEROUS OVARIAN CARCINOMA AND CELL OF ORIGIN&lt;/Title>
   	&lt;PublishedIn>
    	&lt;Publication>
      	&lt;/Publication>
   	&lt;/PublishedIn>
   	&lt;PublicationDate>2025-08&lt;/PublicationDate>
   	&lt;DOI>https://doi.org/10.7298/vdcb-2a28&lt;/DOI>
   	&lt;Authors>
      	&lt;Author>
        	&lt;DisplayName>Phuong, Daryl&lt;/DisplayName>
         	&lt;Affiliation>
         		&lt;OrgUnit>
         		&lt;/OrgUnit>
         	&lt;/Affiliation>
      	&lt;/Author>
	&lt;/Authors>
   	&lt;Editors>
	&lt;/Editors>
    &lt;Publishers>
        &lt;Publisher>
            &lt;OrgUnit />
        &lt;/Publisher>
    &lt;/Publishers>
    &lt;License>https://creativecommons.org/licenses/by-nc-nd/4.0/&lt;/License>
    &lt;Keyword>Cancer&lt;/Keyword>
    &lt;Keyword>CRISPR&lt;/Keyword>
    &lt;Keyword>Drugs&lt;/Keyword>
    &lt;Keyword>Genes&lt;/Keyword>
    &lt;Keyword>Organoids&lt;/Keyword>
    &lt;Keyword>Ovarian&lt;/Keyword>
   	&lt;Abstract>By 2050, ovarian cancer deaths are projected to exceed 350,000 annually, a 70% increase from 2022. Of these, 70% will be high-grade serous ovarian carcinoma (HGSC), the most aggressive subtype. Understanding HGSC is crucial for improving patient outcomes, but research has been hindered by a lack of recurrent mutations aside from TP53 and challenges related to the homologous recombination deficiency of HGSC, which can lead to significant genome loss. In my studies, I demonstrate that tubal epithelial (TE) organoids from the mouse uterine tube can be used in combinatorial screening to identify HGSC drivers and cell of origin. Using CRISPR knockout libraries, we found that Map2k4 mutations primarily form papillary tumor phenotypes, while Nf1 mutations lead to mesenchymal phenotypes. Map2k4 mutations were more sensitive to paclitaxel and resistant to trametinib. Additionally, TE organoid models closely reflect their in vivo counterparts, with SLC1A3+ cells more likely to form organoids and exhibit ciliation. These findings highlight the potential of TE organoid models for studying HGSC genetic drivers and the cell of origin. Overall, I demonstrate the potential of this system for use in future human studies, particularly in exploring spontaneous mutations caused by tumor promoting environmental factors. These findings could lead to the development of a more thorough diagnostic and prognostic pipeline and database that help monitor and improve patient survival.&lt;/Abstract>
	&lt;Access xmlns="http://purl.org/coar/access_right" 
    >
    &lt;/Access>
&lt;/Publication>
</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>